Wagner Macula & Retina Center

Norfolk, Virginia 23502

1 studies enrolling now · 12 studies all time

What they study most

Diabetes Mellitus, Diabetic Macular Edema, Diabetic Macular Edema(DME), Diabetic Retinopathy, Geographic Atrophy, Macular Degeneration, Neovascular (Wet) Age-related Macular Degeneration, Neovascular Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration, Subretinal Edema, Vitreomacular Traction

Studies at this site

• A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD — Recruiting now
• A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema — Completed
• A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE) — Completed
• A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema — Completed
• A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration — Completed
• Home OCT Fluid Visualization Agreement Study — Status unconfirmed
• Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration — Completed
• Treatment of Post-Ocriplasmin Therapy Vitreolysis Induced Subretinal Fluid With Eplerenone (Mineralocorticoid Antagonists) — Stopped early
• The Study to YD312 Tablet in Patients With Diabetic Macular Edema — Status unconfirmed
• A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy — Completed
• An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy — Stopped early
• A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration — Stopped early